Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Classification of Tumours, Revised 4th Edition, Volume 2. International Agency for Research on Cancer; 2017.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Lin L, Yan L, Liu Y, Yuan F, Li H, Ni J. Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study. J Hematol Oncol. 2019;12:96. https://doi.org/10.1186/s13045-019-0783-9.

Article  PubMed  PubMed Central  Google Scholar 

Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020:10. https://doi.org/10.1101/cshperspect.a034819.

Du M, Chen W, Liu K, Wang L, Hu Y, Mao Y, et al. The Global burden of leukemia and its attributable factors in 204 countries and territories: Findings from the global burden of disease 2019 study and projections to 2030. J Oncol. 2022;2022:1612702. https://doi.org/10.1155/2022/1612702.

Article  PubMed  PubMed Central  Google Scholar 

Dalamaga M, Petridou E, Cook FE, Trichopoulos D. Risk factors for myelodysplastic syndromes: A case-control study in Greece. Cancer Causes Control. 2002;13:603–8. https://doi.org/10.1023/a:1019573319803.

Article  PubMed  Google Scholar 

Hao T, Li-Talley M, Buck A, Chen W. An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci Rep. 2019;9:12070. https://doi.org/10.1038/s41598-019-48445-1.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dalamaga M, Lekka A, Karmaniolas K, Stathopoulou E, Dionyssiou-Asteriou A. Is thyroid autoimmunity a risk factor for developing primary myelodysplastic syndrome? Cancer Causes Control. 2008;19:371–8. https://doi.org/10.1007/s10552-007-9096-3.

Article  PubMed  Google Scholar 

Dalamaga M, Crotty BH, Fargnoli J, Papadavid E, Lekka A, Triantafilli M, et al. B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: A case-control study in Greece. Cancer Causes Control. 2010;21:1451–9. https://doi.org/10.1007/s10552-010-9573-y.

Article  PubMed  PubMed Central  Google Scholar 

Petridou E, Dalamaga M, Mentis A, Skalkidou A, Moustaki M, Karpathios T, et al. Evidence on the infectious etiology of childhood leukemia: The role of low herd immunity (Greece). Cancer Causes Control. 2001;12:645–52. https://doi.org/10.1023/a:1011255825887.

Article  PubMed  CAS  Google Scholar 

Lichtman MA. Obesity and the risk for a hematological malignancy: Leukemia, lymphoma, or myeloma. Oncologist. 2010;15:1083–101. https://doi.org/10.1634/theoncologist.2010-0206.

Article  PubMed  PubMed Central  Google Scholar 

Hroussalas G, Kassi E, Dalamaga M, Delimaris I, Zachari A, Dionyssiou-Asteriou A. Leptin, soluble leptin receptor, adiponectin and resistin in relation to OGTT in overweight/obese postmenopausal women. Maturitas. 2008;59:339–49. https://doi.org/10.1016/j.maturitas.2008.03.012.

Article  PubMed  CAS  Google Scholar 

Kassi E, Dalamaga M, Faviou E, Hroussalas G, Kazanis K, Nounopoulos C, et al. Circulating oxidized LDL levels, current smoking and obesity in postmenopausal women. Atherosclerosis. 2009;205:279–83. https://doi.org/10.1016/j.atherosclerosis.2008.11.006.

Article  PubMed  CAS  Google Scholar 

Paroutoglou K, Papadavid E, Christodoulatos GS, Dalamaga M. Deciphering the association between psoriasis and obesity: Current evidence and treatment considerations. Curr Obes Rep. 2020;9:165–78. https://doi.org/10.1007/s13679-020-00380-3.

Article  PubMed  Google Scholar 

Koliaki C, Liatis S, Dalamaga M, Kokkinos A. The implication of gut hormones in the regulation of energy homeostasis and their role in the pathophysiology of obesity. Curr Obes Rep. 2020;9:255–71. https://doi.org/10.1007/s13679-020-00396-9.

Article  PubMed  Google Scholar 

Stratigou T, Dalamaga M, Antonakos G, Marinou I, Vogiatzakis E, Christodoulatos GS, et al. Hyperirisinemia is independently associated with subclinical hypothyroidism: Correlations with cardiometabolic biomarkers and risk factors. Endocrine. 2018;61:83–93. https://doi.org/10.1007/s12020-018-1550-3.

Article  PubMed  CAS  Google Scholar 

Fogarasi A, Gonzalez K, Dalamaga M, Magkos F. The impact of the rate of weight loss on body composition and metabolism. Curr Obes Rep. 2022;11:33–44. https://doi.org/10.1007/s13679-022-00470-4.

Article  PubMed  Google Scholar 

WHO. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed on March 25, 2023.

Liu J, Tsilingiris D, Dalamaga M. The non-linear relationship between muscle mass and BMI calls into question the use of BMI as a major criterion for eligibility for bariatric surgery. Metabol Open. 2022;13:100164. https://doi.org/10.1016/j.metop.2022.100164.

Article  PubMed  PubMed Central  Google Scholar 

Simati S, Kokkinos A, Dalamaga M, Argyrakopoulou G. Obesity paradox: Fact or fiction? Curr Obes Rep. 2023;12:75–85. https://doi.org/10.1007/s13679-023-00497-1.

Article  PubMed  Google Scholar 

Afshin A, Reitsma MB, Murray CJL. Health effects of overweight and obesity in 195 countries. N Engl J Med. 2017;377:1496–7. https://doi.org/10.1056/NEJMc1710026.

Article  PubMed  Google Scholar 

Karampela I, Vallianou N, Magkos F, Apovian CM, Dalamaga M. Obesity, hypovitaminosis D, and COVID-19: The Bermuda triangle in public health. Curr Obes Rep. 2022;11:116–25. https://doi.org/10.1007/s13679-022-00471-3.

Article  PubMed  PubMed Central  Google Scholar 

Cardel MI, Atkinson MA, Taveras EM, Holm JC, Kelly AS. Obesity treatment among adolescents: A review of current evidence and future directions. JAMA Pediatr. 2020;174:609–17. https://doi.org/10.1001/jamapediatrics.2020.0085.

Article  PubMed  PubMed Central  Google Scholar 

Spyrou N, Vallianou N, Kadillari J, Dalamaga M. The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era. Semin Cancer Biol. 2021;73:356–76. https://doi.org/10.1016/j.semcancer.2021.05.008.

Article  PubMed  CAS  Google Scholar 

Tsilingiris D, Liatis S, Dalamaga M, Kokkinos A. The fight against obesity escalates: New Drugs on the horizon and metabolic implications. Curr Obes Rep. 2020;9:136–49. https://doi.org/10.1007/s13679-020-00378-x.

Article  PubMed  Google Scholar 

Tsigalou C, Vallianou N, Dalamaga M. Autoantibody production in obesity: Is there evidence for a link between obesity and autoimmunity? Curr Obes Rep. 2020;9:245–54. https://doi.org/10.1007/s13679-020-00397-8.

Article  PubMed  Google Scholar 

Dalamaga M, Papadavid E, Basios G, Vaggopoulos V, Rigopoulos D, Kassanos D, et al. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: A prospective controlled study. J Am Acad Dermatol. 2013;69:922–30. https://doi.org/10.1016/j.jaad.2013.09.014.

Article  PubMed  CAS  Google Scholar 

Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794–8. https://doi.org/10.1056/NEJMsr1606602.

Article  PubMed  PubMed Central  Google Scholar 

Larsson SC, Spyrou N, Mantzoros CS. Body fatness associations with cancer: Evidence from recent epidemiological studies and future directions. Metabolism. 2022;137:155326. https://doi.org/10.1016/j.metabol.2022.155326.

Article  PubMed  CAS  Google Scholar 

Castillo JJ, Reagan JL, Ingham RR, Furman M, Dalia S, Merhi B, et al. Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies. Leuk Res. 2012;36:868–75. https://doi.org/10.1016/j.leukres.2011.12.020.

Article  PubMed  Google Scholar 

Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: A meta-analysis of cohort studies. Int J Cancer. 2008;122:1418–21. https://doi.org/10.1002/ijc.23176.

Article  PubMed  CAS  Google Scholar 

Lichtman MA. Obesity and the risk of chronic myelogenous leukemia: Is this another example of the neoplastic effects of increased body fat? Leukemia. 2012;26:183–4. https://doi.org/10.1038/leu.2011.190.

Article  PubMed  CAS  Google Scholar 

Teras LR, Patel AV, Carter BD, Rees-Punia E, McCullough ML, Gapstur SM. Anthropometric factors and risk of myeloid leukaemias and myelodysplastic syndromes: A prospective study and meta-analysis. Br J Haematol. 2019;186:243–54. https://doi.org/10.1111/bjh.15904.

Article  PubMed  CAS  Google Scholar 

Poynter JN, Richardson M, Blair CK, Roesler MA, Hirsch BA, Nguyen P, et al. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes. Cancer Epidemiol. 2016;40:134–40. https://doi.org/10.1016/j.canep.2015.12.005.

Article  PubMed  Google Scholar 

Dalamaga M, Karmaniolas K, Lekka A, Antonakos G, Thrasyvoulides A, Papadavid E, et al. Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. Dis Markers. 2010;29:55–61. https://doi.org/10.3233/dma-2010-0726.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bhaskaran K, Douglas I, Forbes H, dos Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: A popul